Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2007, Article ID 76271, 6 pages
http://dx.doi.org/10.1155/2007/76271
Research Article

Diabetic Retinopathy in Native and Nonnative Canadians

1Faculty of medicine, University of Calgary, # 238-4411 16th Ave NW, Calgary, AB T3B 0M3, Canada
2Grant MacEwan College, 5-225K City Centre Campus, Edmonton, AB T5J 4S2, Canada
3Department of community health, University of Calgary, 29th St Northwest, Calgary, AB T2N 1N4, Canada

Received 18 March 2007; Accepted 12 July 2007

Academic Editor: Subrata Chakrabarti

Copyright © 2007 Stuart A. Ross et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. E. Klein, R. Klein, S. E. Moss, and M. Palta, “A cohort study of the relationship of diabetic retinopathy to blood pressure,” Archives of Ophthalmology, vol. 113, no. 5, pp. 601–606, 1995. View at Google Scholar
  2. B. E. Klein, R. Klein, S. E. Moss, and M. Palta, “Erratum: a cohort study of the relationship of diabetic retinopathy to blood pressure,” Archives of Ophthalmology, vol. 114, no. 1, p. 109, 1995. View at Google Scholar
  3. R. Klein, B. E. Klein, S. E. Moss, M. D. Davis, and D. L. DeMets, “Is blood pressure a predictor of the incidence or progression of diabetic retinopathy?” Archives of Internal Medicine, vol. 149, no. 11, pp. 2427–2432, 1989. View at Publisher · View at Google Scholar
  4. R. Klein, B. E. Klein, S. E. Moss, M. D. Davis, and D. L. DeMets, “Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy,” Journal of the American Medical Association, vol. 260, no. 19, pp. 2864–2871, 1988. View at Publisher · View at Google Scholar
  5. B. E. Klein, S. E. Moss, and R. Klein, “Longitudinal measure of glycemic control and diabetic retinopathy,” Diabetes Care, vol. 10, no. 3, pp. 273–277, 1987. View at Publisher · View at Google Scholar
  6. E. Y. Chew, M. L. Klein, F. L. Ferris III et al., “Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy: early treatment diabetic retinopathy study (ETDRS) report 22,” Archives of Ophthalmology, vol. 114, no. 9, pp. 1079–1084, 1996. View at Google Scholar
  7. R. Klein, B. E. Klein, S. E. Moss, and K. J. Cruickshanks, “The Wisconsin epidemiologic study of diabetic retinopathy: XIV. Ten-year incidence and progression of diabetic retinopathy,” Archives of Ophthalmology, vol. 112, no. 9, pp. 1217–1228, 1994. View at Google Scholar
  8. S. B. Harris, B. Zinman, A. Hanley et al., “The impact of diabetes on cardiovascular risk factors and outcomes in a native Canadian population,” Diabetes Research and Clinical Practice, vol. 55, no. 2, pp. 165–173, 2002. View at Publisher · View at Google Scholar
  9. S. G. Bruce, “The impact of diabetes mellitus among the Métis of western Canada,” Ethnicity & Health, vol. 5, no. 1, pp. 47–57, 2000. View at Publisher · View at Google Scholar
  10. S. B. Harris, J. Gittelsohn, A. Hanley et al., “The prevalence of NIDDM and associated risk factors in native Canadians,” Diabetes Care, vol. 20, no. 2, pp. 185–187, 1997. View at Publisher · View at Google Scholar
  11. A. J. G. Hanley, S. B. Harris, M. Mamakeesick et al., “Complications of type 2 diabetes among aboriginal Canadians: prevalence and associated risk factors,” Diabetes Care, vol. 28, no. 8, pp. 2054–2057, 2005. View at Google Scholar
  12. J.-M. Ekoe, J.-P. Thouez, C. Petitclerc, P. M. Foggin, and P. Ghadirian, “Epidemiology of obesity in relationship to some chronic medical conditions among Inuit and Cree Indian populations in New Quebec, Canada,” Diabetes Research and Clinical Practice, vol. 10, 1, pp. S17–S27, 1990. View at Publisher · View at Google Scholar
  13. A. C. Macaulay, L. T. Montour, and N. Adelson, “Prevalence of diabetic and atherosclerotic complications among Mohawk Indians of Kahnawake, PQ,” Canadian Medical Association Journal, vol. 139, no. 3, pp. 221–224, 1988. View at Google Scholar
  14. P. H. Bennett, N. B. Rushforth, M. Miller, and P. M. LeCompte, “Epidemiologic studies of diabetes in the Pima Indians,” Recent Progress in Hormone Research, vol. 32, pp. 333–376, 1976. View at Google Scholar
  15. S. Evers, E. McCracken, I. Antone, and G. Deagle, “The prevalence of diabetes in Indians and Caucasians living in Southwestern Ontario,” Canadian Journal of Public Health, vol. 78, no. 4, pp. 240–243, 1987. View at Google Scholar
  16. L. T. Montour and A. C. Macaulay, “High prevalence rates of diabetes mellitus and hypertension on a North American Indian reservation,” Canadian Medical Association Journal, vol. 132, no. 10, pp. 1110–1112, 1985. View at Google Scholar
  17. S. B. Harris, J. Gittelsohn, A. Hanley et al., “The prevalence of NIDDM and associated risk factors in native Canadians,” Diabetes Care, vol. 20, no. 2, pp. 185–187, 1997. View at Google Scholar
  18. T. K. Young and S. B. Harris, “Risk of clinical diabetes in a northern Native Canadian cohort,” Arctic Medical Research, vol. 53, no. 2, pp. 64–70, 1994. View at Google Scholar
  19. P. Brassard, E. Robinson, and C. Lavallee, “Prevalence of diabetes mellitus among the James Bay Cree of northern Quebec,” Canadian Medical Association Journal, vol. 149, no. 3, pp. 303–307, 1993. View at Google Scholar
  20. H. J. Dean, R. L. Mundy, and M. Moffatt, “Non-insulin-dependent diabetes mellitus in Indian children in Manitoba,” Canadian Medical Association Journal, vol. 147, no. 1, pp. 52–57, 1992. View at Google Scholar
  21. E. J. E. Szathmary and N. Holt, “Hyperglycemia in Dogrib Indians of the Northwest territories, Canada: association with age and a centripetal distribution of body fat,” Human Biology, vol. 55, no. 2, pp. 493–515, 1983. View at Google Scholar
  22. T. K. Young, “Diabetes mellitus among native Americans in Canada and the United States: an epidemiological review,” American Journal of Human Biology, vol. 5, no. 4, pp. 399–413, 1993. View at Publisher · View at Google Scholar
  23. T. K. Young, J. M. Kaufert, J. K. McKenzie, A. Hawkins, and J. O'Neil, “Excessive burden of end-state renal disease among Canadian Indians: a national survey,” American Journal of Public Health, vol. 79, no. 6, pp. 756–758, 1989. View at Google Scholar
  24. P. J. Dyck, K. M. Kratz, J. L. Karnes et al., “The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study,” Neurology, vol. 43, no. 4, pp. 817–824, 1993. View at Google Scholar
  25. P. J. Dyck, K. M. Kratz, J. L. Karnes et al., “Erratum: the prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study,” Neurology, vol. 43, no. 11, p. 2345, 1993. View at Google Scholar
  26. R. F. Dyck and L. Tan, “Rates and outcomes of diabetic end-stage renal disease among registered native people in Saskatchewan,” Canadian Medical Association Journal, vol. 150, no. 2, pp. 203–208, 1994. View at Google Scholar
  27. P. Brassard, E. Robinson, and C. Dumont, “Descriptive epidemiology of non-insulin-dependent diabetes mellitus in the James Bay Cree population of Quebec, Canada,” Arctic Medical Research, vol. 52, no. 2, pp. 47–54, 1993. View at Google Scholar
  28. J. D. Martin and H. M. Yidegiligne, “Diabetes mellitus in the first nations population of British Columbia, Canada,” International Journal of Circumpolar Health, vol. 57, 1, pp. 335–339, 1998. View at Google Scholar
  29. S. M. Haffner, B. D. Mitchell, S. E. Moss et al., “Is there an ethnic difference in the effect of risk factors for diabetic retinopathy?” Annals of Epidemiology, vol. 3, no. 1, pp. 2–8, 1993. View at Google Scholar
  30. D. K. Nagi, D. J. Pettitt, P. H. Bennett, R. Klein, and W. C. Knowler, “Diabetic retinopathy assessed by fundus photography in Pima Indians with impaired glucose tolerance and NIDDM,” Diabetic Medicine, vol. 14, no. 6, pp. 449–456, 1997. View at Publisher · View at Google Scholar
  31. D. A. L. Maberley, H. Hollands, A. Chang, S. Adilman, B. Chakraborti, and G. Kliever, “The prevalence of low vision and blindness in a Canadian inner city,” Eye, vol. 21, no. 4, pp. 528–533, 2007. View at Publisher · View at Google Scholar
  32. A. Dorf, E. J. Ballintine, P. H. Bennett, and M. Miller, “Retinopathy in Pima Indians. Relationships to glucose level, duration of diabetes, age at diagnosis of diabetes, and age at examination in a population with a high prevalence of diabetes mellitus,” Diabetes, vol. 25, no. 7, pp. 554–560, 1976. View at Publisher · View at Google Scholar
  33. A. Teuscher, H. Schnell, and P. W. F. Wilson, “Incidence of diabetic retinopathy and relationship to baseline plasma glucose and blood pressure,” Diabetes Care, vol. 11, no. 3, pp. 246–251, 1988. View at Publisher · View at Google Scholar
  34. B. E. Klein and R. Klein, “Diabetic retinopathy: possible etiological role of hyperglycemia,” Pediatrician, vol. 17, no. 3, pp. 177–182, 1990. View at Google Scholar
  35. The diabetes control and complications trial research group, “The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus,” New England Journal of Medicine, vol. 329, no. 14, pp. 977–986, 1993. View at Publisher · View at Google Scholar
  36. P. Gæde, P. Vedel, N. Larsen, G. V. H. Jensen, H.-H. Parving, and O. Pedersen, “Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes,” New England Journal of Medicine, vol. 348, no. 5, pp. 383–393, 2003. View at Google Scholar
  37. R. Klein, B. E. Klein, S. E. Moss, and Q. Wang, “Blood pressure, hypertension and retinopathy in a population,” Transactions of the American Ophthalmological Society, vol. 91, pp. 207–226, 1993. View at Google Scholar
  38. J. M. Lewis, L. Jovanovic-Peterson, I. Ahmadizadeh, W. Bevier, C. M. Peterson, and B. Williams, “The Santa Barbara County diabetic retinopathy screening feasibility study: significance of diabetes duration and systolic blood pressure,” Journal of Diabetes and Its Complications, vol. 8, no. 1, pp. 51–54, 1994. View at Publisher · View at Google Scholar
  39. B. E. Klein, S. E. Moss, R. Klein, and T. S. Surawicz, “Serum cholesterol in Wisconsin epidemiologic study of diabetic retinopathy,” Diabetes Care, vol. 15, no. 2, pp. 282–287, 1992. View at Publisher · View at Google Scholar
  40. B. E. Klein, S. E. Moss, R. Klein, and T. S. Surawicz, “The Wisconsin epidemiologic study of diabetic retinopathy XIII. Relationship of serum cholesterol to retinopathy and hard exudate,” Ophthalmology, vol. 98, no. 8, pp. 1261–1265, 1991. View at Google Scholar
  41. R. Klein, B. E. Klein, and S. E. Moss, “Epidemiology of proliferative diabetic retinopathy,” Diabetes Care, vol. 15, no. 12, pp. 1875–1891, 1992. View at Publisher · View at Google Scholar
  42. B. V. Howard and M. F. Magee, “Diabetes and cardiovascular disease,” Current Atherosclerosis Reports, vol. 2, no. 6, pp. 476–481, 2000. View at Publisher · View at Google Scholar
  43. H. F. Delisle, M. Rivard, and J. M. Ekoe, “Prevalence estimates of diabetes and of other cardiovascular risk factors in the two largest Algonquin communities of Quebec,” Diabetes Care, vol. 18, no. 9, pp. 1255–1259, 1995. View at Publisher · View at Google Scholar
  44. R. Klein, B. E. Klein, S. E. Moss, M. D. Davis, and D. L. DeMets, “The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years,” Archives of Ophthalmology, vol. 102, no. 4, pp. 527–532, 1984. View at Google Scholar